पहचान

Apitolisib

सूचीबद्ध नहीं · C23H30N8O3S

01पहचान

Lazychem IDLC-63263
CAS RNसूचीबद्ध नहीं
PubChem CID25254071
Molecular formulaC23H30N8O3S
Molecular weight498.6 g/mol
IUPAC name(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one
InChIKeyYOVVNQKCSKSHKT-HNNXBMFYSA-N

02संरचना और त्रिविम रसायन

2D structurePubChem CID 25254071
Two-dimensional chemical structure of Apitolisib
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count5
Secondary amines0
Tertiary amines2
SMILESCC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)[C@H](C)O
InChIसूचीबद्ध नहीं

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04भारत में स्थिति

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05नाम और संबंध

API और मूल औषधि

सूचीबद्ध नहीं

नाम और संबंध

    अशुद्धियाँ और संबंधित यौगिक

      06स्रोत